Periportal Hepatic Necrosis in Reye's Syndrome

Bentz, Michael S.; Cohen, Cynthia
January 1980
American Journal of Gastroenterology;Jan1980, Vol. 73 Issue 1, p49
Academic Journal
Hepatic necrosis, usually periportal and mild but occasionally of significant extent, is described in the liver of patients with Reye's syndrome, in addition to diffuse microvesicular fatty change. Review of clinical and pathologic findings of eight cases of Reye's syndrome diagnosed between 1970-1978 showed extensive peripheral lobular necrosis of hepatocytes in one case. Other than biochemical evidence of greater liver damage, the latter case showed no significant differences in clinical and laboratory findings from the seven cases with diffuse fatty change of hepatocytes but no liver cell necrosis. The significance of this periportal hepatic necrosis is discussed in the light of current theories concerning the etiology and pathogenesis of Reye's syndrome.


Related Articles

  • Serum leptin level can be a negative marker of hepatocyte damage in nonalcoholic fatty liver. Serin, Ender; Özer, Birol; Gümürdülü, Yüksel; Kayaselçuk, Fazilet; Kul, Kemal; Boyacıoğlu, Sedat // Journal of Gastroenterology;2003, Vol. 38 Issue 5, p471 

    Background. The aim of this study was to determine whether leptin and insulin resistance (IR) showed differences between steatotic patients with and without elevated serum transaminases. Methods. The study included 32 patients with fatty liver and high serum transaminase level (group I), 31...

  • Hepatoprotective activity of Leptadenia reticulata stems against carbon tetrachloride-induced hepatotoxicity in rats. Nema, Amit Kumar; Agarwal, Abhinav; Kashaw, Varsha // Indian Journal of Pharmacology;Jun2011, Vol. 43 Issue 3, p254 

    Objective: To evaluate the hepatoprotective activity of ethanolic and aqueous extract of stems of Leptadenia reticulata (Retz.) Wight. and Arn. in carbon tetrachloride (CCl4)-induced hepatotoxicity in rats. Materials and Methods: The toxicant CCl4 was used to induce hepatotoxicity at a dose of...

  • Reye's Syndrome-Like Illness in a Patient Receiving Amiodarone. Jones, D. Brian; Mullick, Florabel G.; Hoofnagle, Jay H.; Baranski, Bruce // American Journal of Gastroenterology;Sep1988, Vol. 83 Issue 9, p967 

    A 16-yr-old boy who was receiving amiodarone for ventricular arrhythmias developed a Reye's syndrome-like illness several days after an upper respiratory infection. Liver biopsy revealed microvesicular fat and spotty hepatocellular necrosis, typical of Reye's syndrome. Recovery was complete....

  • Hepatocellular carcinoma and NASH. Kudo, Masatoshi // Journal of Gastroenterology;2004, Vol. 39 Issue 4, p409 

    Nonalcoholic fatty liver disease (NAFLD) has a spectrum ranging from fatty liver alone to steatohepatitis, steatonecrosis, and nonalcoholic steatohepatitis (NASH). Risk factors associated with NAFLD include obesity, type II diabetes mellitus, hyperlipidemia, jejunoileal bypass, and drugs. NASH,...

  • Detection of alcohol-induced fatty liver by computerized tomography. Allaway, S. L.; Ritchie, C. D.; Robinson, D.; Seear, T.; Reznek, R.; Kelsey Fry, I.; Thompson, G. R. // Journal of the Royal Society of Medicine;Mar1988, Vol. 81 Issue 3, p149 

    Computerized tomographic (CT) scanning of the liver was undertaken in 17 occasional and 19 heavy drinkers undergoing health screening. The median attenuation value of the liver (CT number) in occasional drinkers with normal liver function tests was 54.4 compared with 25.9 in the heavy drinkers...

  • Adult Reye's syndrome. Al-Tikriti, S. A.; Rowe, P. A.; Munro, A. J. // Journal of the Royal Society of Medicine;Aug1984, Vol. 77 Issue 8, p694 

    The article focuses on the Adult Reye's syndrome. Reye's syndrome is characterized by encephalopathy and fatty degeneration of the liver and other viscera. This condition typically presents in infancy or childhood but has been reported in adults. It happens in adults since appropriate treatment...

  • Research progress in association between nonalcoholic fatty liver disease and gallstone disease. HUANG Ying; CHEN Hong // Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi;nov2014, Vol. 30 Issue 11, p1217 

    Nonalcoholic fatty liver disease (NAFLD) and gallstone disease (GD) are considered the manifestations of metabolic syndrome in the liver and gallbladder. NAFLD and GD are closely related to insulin resistance (IR), obesity, dyslipidemia, abnormal glucose metabolism, and so on. Worldwide studies,...

  • Research progress in roles of gut microbiota and bile acid metabolism in development and progression of NAFLD. LU Xu; HAN Tao; TIAN Yao // Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi;nov2014, Vol. 30 Issue 11, p1225 

    With the prevalence of obesity and metabolic syndrome, the incidence of nonalcoholic fatty liver disease (NAFLD) is increasing year by year. Studies have uncovered the important roles of gut microbiota and bile acid metabolism in the development and progression of NAFLD. The roles of gut...

  • Reye Syndrome Surveillance -- United States, 1987 and 1988.  // Clinical Pediatrics;Feb1990, Vol. 29 Issue 2, p125 

    This article focuses on Reye's syndrome (RS) surveillance that held in the United States in 1987 and 1988. For the 1987 and 1988 surveillance years, 36 and 20 cases, respectively, of RS were reported to the National Reye Syndrome Surveillance System. These years have the lowest number of cases...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics